This book provides a comprehensive survey of the pharmacokinetic models used for the quantitative interpretation of contrast-enhanced imaging. It discusses all the available imaging technologies and the problems related to the calibration of the imaging system and accuracy of the estimated physiological parameters. Enhancing imaging modalities using contrast agents has opened up new opportunities for going beyond morphological information and enabling minimally invasive assessment of tissue and organ functionality down to the molecular level. In combination with mathematical modeling of the contrast agent kinetics, contrast- enhanced imaging has the potential to provide clinically valuable additional information by estimating quantitative p...
This work is focussed on the analysis of breast tumour physiology by pharmacokinetic modelling of dy...
Accurate and sensitive discrimination of cancerous tissue from the healthy tissue has been a difficu...
To evaluate the relationship between dynamic contrast agent–enhanced magnetic resonance (MR) imaging...
This book provides a comprehensive survey of the pharmacokinetic models used for the quantitative in...
Abnormal microcirculation is a feature of many neoplastic and non-neoplastic diseases. Physiological...
The so-called "Kety model" is a two-compartment pharmacokinetic model describing tumor perfusion kin...
Dynamic Contrast Enhanced MRI is an important technique to assess the pharmacokinetic properties of ...
The so-called "Kety model" is a two-compartment pharmacokinetic model describing tumor perfusion kin...
Optimization of experimental settings of dynamic contrast-enhanced magnetic resonance imaging (DCE-M...
Optimization of experimental settings of dynamic contrast-en-hanced magnetic resonance imaging (DCE-...
There is rapidly increasing interest in functional imaging for the diagnosis and monitoring of disea...
Background: Dynamic contrast-enhanced MRI (DCE-MRI) has the potential to produce images of physiolog...
Item does not contain fulltextA method is presented for the acquisition and analysis of dynamic cont...
This work is focussed on the analysis of breast tumour physiology by pharmacokinetic modelling of dy...
Accurate and sensitive discrimination of cancerous tissue from the healthy tissue has been a difficu...
To evaluate the relationship between dynamic contrast agent–enhanced magnetic resonance (MR) imaging...
This book provides a comprehensive survey of the pharmacokinetic models used for the quantitative in...
Abnormal microcirculation is a feature of many neoplastic and non-neoplastic diseases. Physiological...
The so-called "Kety model" is a two-compartment pharmacokinetic model describing tumor perfusion kin...
Dynamic Contrast Enhanced MRI is an important technique to assess the pharmacokinetic properties of ...
The so-called "Kety model" is a two-compartment pharmacokinetic model describing tumor perfusion kin...
Optimization of experimental settings of dynamic contrast-enhanced magnetic resonance imaging (DCE-M...
Optimization of experimental settings of dynamic contrast-en-hanced magnetic resonance imaging (DCE-...
There is rapidly increasing interest in functional imaging for the diagnosis and monitoring of disea...
Background: Dynamic contrast-enhanced MRI (DCE-MRI) has the potential to produce images of physiolog...
Item does not contain fulltextA method is presented for the acquisition and analysis of dynamic cont...
This work is focussed on the analysis of breast tumour physiology by pharmacokinetic modelling of dy...
Accurate and sensitive discrimination of cancerous tissue from the healthy tissue has been a difficu...
To evaluate the relationship between dynamic contrast agent–enhanced magnetic resonance (MR) imaging...